Technology
Health
Biotechnology

22nd Century Group

$1.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.02 (-1.04%) Today
+$0.03 (1.57%) As of 5:09 PM EDT after-hours

Why Robinhood?

You can buy or sell XXII and other stocks, options, ETFs, and crypto commission-free!

About XXII

22nd Century Group Inc., also called 22nd Century Group, is a plant biotechnology company, which engages in the development of technology that will allow to increase or decrease the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes, and verfola. Read More The company was founded on September 12, 2005 and is headquartered in Clarence, NY.

Employees
82
Headquarters
Clarence, New York
Founded
2005
Market Cap
240.59M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
846.34K
High Today
$1.96
Low Today
$1.90
Open Price
$1.93
Volume
918.64K
52 Week High
$3.29
52 Week Low
$1.58

Collections

Technology
Health
Biotechnology
Engineering
US
North America

XXII Earnings

-$0.07
-$0.03
$0.01
$0.05
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 6, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.